Javier Piraino, DO
Urology · Charlotte, NCNPI 1013443167
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Boston Scientific at 35.2% of the total.
Across 126 payments — averaging $76.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Coloplast$3K
- C. R. Bard, Inc. & Subsidiaries$650
- Medtronic$599
- Endo USA, Inc.$545
- Urogen Pharma, Inc.$372
- plus $857 from 10 others
What the payments were for
- Speaking & faculty fees$6507%
- Travel & lodging$3,69338%
- Food & beverage$5,26055%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 47 | $3,380 |
| Coloplast | 34 | $3,199 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $650 |
| Medtronic | 6 | $599 |
| Endo USA, Inc. | 19 | $545 |
| Urogen Pharma, Inc. | 2 | $372 |
| Calyxo, Inc. | 4 | $310 |
| Procept Biorobotics Corporation | 4 | $172 |
| Axonics, Inc. | 2 | $119 |
| Olympus America Inc. | 1 | $108 |
| Blue Earth Diagnostics | 1 | $35 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Incyte Corporation | 1 | $22 |
| Progenics Pharmaceuticals, Inc. | 1 | $20 |
| Ambu Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$2,469
- INTERSTIM$452
- AMS 700 CXR RTE KIT$377
- JELMYTO$372
- AdVance XP$339
- CVAC Aspiration System$279
- LithoVue$268
- AMS 700$236
- XIAFLEX$139
- GENERAL ERECTILE DYSFUNCTION$138
- GENERAL KIDNEY STONE DISEASE$125
- AQUABEAM SYSTEM$113
How this compares
$9,603 in reported general payments places this provider in the 80th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $1,429 |
| Tamsulosin Hcl | 25 | $376 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 50 | $112 |
| Ciprofloxacin Hcl | 12 | $72 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $53 |
| Oxycodone Hcl | 19 | $52 |
| Gabapentin | 13 | $37 |
| Meloxicam | 15 | $33 |
Paid to pharmacies, not to this prescriber.
Other urology in Charlotte
- Michael KennellyCharlotte$1.3M
- Manish PatelCharlotte$84K
- Kris GastonCharlotte$32K
- Todd CohenCharlotte$18K
- Ornob RoyCharlotte$17K
- Maxim McKibbenCharlotte$15K
- Robert LippittSmithfield$11.4M
- John KasparRaleigh$1.1M
- Judd MoulDurham$1M
- Daniel GeorgeDurham$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.